{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:25:01Z","timestamp":1787646301316,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["65814"],"award-info":[{"award-number":["65814"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"DOI":"10.1007\/s00787-026-03171-8","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:28:04Z","timestamp":1787642884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ropinirole adjunct to methylphenidate versus placebo adjunct to methylphenidate for attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1007","author":[{"given":"Aidin","family":"Farahvash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Naseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Morovvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Shamabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina Motaghian","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Mobini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"5","key":"3171_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-0040-1701658","volume":"51","author":"R Drechsler","year":"2020","unstructured":"Drechsler R, Brem S, Brandeis D, Gr\u00fcnblatt E, Berger G, Walitza S (2020) ADHD: Current Concepts and Treatments in Children and Adolescents. Neuropediatrics 51(5):315\u2013335. https:\/\/doi.org\/10.1055\/s-0040-1701658","journal-title":"Neuropediatrics"},{"key":"3171_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano G, Demelash S, Gizachew Y, Tsegay L, Alati R (2023) The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. J Affect Disord 339:860\u2013866. https:\/\/doi.org\/10.1016\/j.jad.2023.07.071","journal-title":"J Affect Disord"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"1551672","DOI":"10.3389\/fpsyt.2025.1551672","volume":"16","author":"L Gao","year":"2025","unstructured":"Gao L, Yang P, Hu B, Zhang Y, Liu Z, Wang X (2025) Comparative analysis of Attention Deficit Hyperactivity Disorder in China and worldwide based on the Global Burden of Disease study. Front Psychiatry 16:1551672. https:\/\/doi.org\/10.3389\/fpsyt.2025.1551672","journal-title":"Front Psychiatry"},{"key":"3171_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-025-01880-w","author":"F Yang","year":"2025","unstructured":"Yang F, Chen R, Xiong J, Liu B (2025) Disease Burden of Autism Spectrum Disorder and Attention - Deficit\/Hyperactivity Disorder in the 0\u201314 Age Group across 204 Countries and Regions from 1990 To 2021. Child Psychiatry Hum Dev. https:\/\/doi.org\/10.1007\/s10578-025-01880-w","journal-title":"Child Psychiatry Hum Dev"},{"issue":"1","key":"3171_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13696998.2022.2032097","volume":"25","author":"J Schein","year":"2022","unstructured":"Schein J, Adler LA, Childress A, Cloutier M, Gagnon-Sanschagrin P, Davidson M, Kinkead F, Guerin A, Lefebvre P (2022) Economic burden of attention-deficit\/hyperactivity disorder among children and adolescents in the United States: a societal perspective. J Med Econ 25(1):193\u2013205. https:\/\/doi.org\/10.1080\/13696998.2022.2032097","journal-title":"J Med Econ"},{"issue":"3","key":"3171_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41380-018-0116-3","volume":"24","author":"A Caye","year":"2019","unstructured":"Caye A, Swanson JM, Coghill D, Rohde LA (2019) Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry 24(3):390\u2013408. https:\/\/doi.org\/10.1038\/s41380-018-0116-3","journal-title":"Mol Psychiatry"},{"issue":"3","key":"3171_CR7","doi-asserted-by":"publisher","first-page":"Cd009885","DOI":"10.1002\/14651858.CD009885.pub3","volume":"3","author":"OJ Storeb\u00f8","year":"2023","unstructured":"Storeb\u00f8 OJ, Storm MRO, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, Schaug JP, Darling Rasmussen P, Huus CL, Zwi M, Kirubakaran R, Simonsen E, Gluud C (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 3(3):Cd009885. https:\/\/doi.org\/10.1002\/14651858.CD009885.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3171_CR8","doi-asserted-by":"publisher","first-page":"849323","DOI":"10.3389\/fncom.2022.849323","volume":"16","author":"F V\u00e9ronneau-Veilleux","year":"2022","unstructured":"V\u00e9ronneau-Veilleux F, Robaey P, Ursino M, Nekka F (2022) A mechanistic model of ADHD as resulting from dopamine phasic\/tonic imbalance during reinforcement learning. Front Comput Neurosci 16:849323. https:\/\/doi.org\/10.3389\/fncom.2022.849323","journal-title":"Front Comput Neurosci"},{"issue":"2","key":"3171_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/tpsy.Tpsy_14_19","volume":"33","author":"M-H Chen","year":"2019","unstructured":"Chen M-H, Huang K-L, Hsu J-W, Tsai S-J (2019) Treatment-resistant Attention-deficit Hyperactivity Disorder: Clinical Significance, Concept, and Management. Taiwan J Psychiatry 33(2):66\u201375. https:\/\/doi.org\/10.4103\/tpsy.Tpsy_14_19","journal-title":"Taiwan J Psychiatry"},{"issue":"2","key":"3171_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.chc.2007.11.010","volume":"17","author":"B Vitiello","year":"2008","unstructured":"Vitiello B (2008) Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. Child Adolesc Psychiatr Clin N Am 17(2):459\u2013474xi. https:\/\/doi.org\/10.1016\/j.chc.2007.11.010","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"3171_CR11","unstructured":"Rewane A, Patel P, Nagalli S (2024) Ropinirole. StatPearls [Internet]. StatPearls Publishing"},{"issue":"5","key":"3171_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2004.11.007","volume":"32","author":"E Konofal","year":"2005","unstructured":"Konofal E, Arnulf I, Lecendreux M, Mouren MC (2005) Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol 32(5):350\u2013351. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2004.11.007","journal-title":"Pediatr Neurol"},{"issue":"8","key":"3171_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/sleep\/28.8.1007","volume":"28","author":"S Cortese","year":"2005","unstructured":"Cortese S, Konofal E, Lecendreux M, Arnulf I, Mouren MC, Darra F, Dalla Bernardina B (2005) Restless legs syndrome and attention-deficit\/hyperactivity disorder: a review of the literature. Sleep 28(8):1007\u20131013. https:\/\/doi.org\/10.1093\/sleep\/28.8.1007","journal-title":"Sleep"},{"issue":"Pt 1","key":"3171_CR14","doi-asserted-by":"publisher","first-page":"132425","DOI":"10.1016\/j.ijbiomac.2024.132425","volume":"271","author":"AS Neha","year":"2024","unstructured":"Neha AS, Pinky, Hassan MI, Parvez S (2024) Ropinirole reverses the effects of neuroinflammation, and cellular demise by downregulating the MARK4-NF\u03ba\u03b2 signaling system in Alzheimer\u2019s disease. Int J Biol Macromol 271(Pt 1):132425. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132425","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3171_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/a:1007672414239","volume":"26","author":"K Tanaka","year":"2001","unstructured":"Tanaka K, Miyazaki I, Fujita N, Haque ME, Asanuma M, Ogawa N (2001) Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist. Neurochem Res 26(1):31\u201336. https:\/\/doi.org\/10.1023\/a:1007672414239","journal-title":"Neurochem Res"},{"key":"3171_CR16","doi-asserted-by":"publisher","unstructured":"Corona JC (2020) Role of Oxidative Stress and Neuroinflammation in Attention-Deficit\/Hyperactivity Disorder. Antioxid (Basel) 9(11). https:\/\/doi.org\/10.3390\/antiox9111039","DOI":"10.3390\/antiox9111039"},{"issue":"2","key":"3171_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0976-500x.72352","volume":"1","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacotherapeutics 1(2):100\u2013107. https:\/\/doi.org\/10.4103\/0976-500x.72352","journal-title":"J Pharmacol Pharmacotherapeutics"},{"issue":"20","key":"3171_CR18","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association WM (2013) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"3171_CR19","unstructured":"First M, Williams J, Karg R, Association SRAP (2015) Arlington. VA, American Psychiatric Association"},{"key":"3171_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-244x-6-10","volume":"6","author":"A Ghanizadeh","year":"2006","unstructured":"Ghanizadeh A, Mohammadi MR, Yazdanshenas A (2006) Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. BMC Psychiatry 6:10. https:\/\/doi.org\/10.1186\/1471-244x-6-10","journal-title":"BMC Psychiatry"},{"issue":"1","key":"3171_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1073191102009001003","volume":"9","author":"BN Axelrod","year":"2002","unstructured":"Axelrod BN (2002) Validity of the Wechsler abbreviated scale of intelligence and other very short forms of estimating intellectual functioning. Assessment 9(1):17\u201323","journal-title":"Assessment"},{"issue":"4","key":"3171_CR22","first-page":"685","volume":"3","author":"JK Lee","year":"2007","unstructured":"Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, Turner PT, Sullenberger LE, Taylor AJ (2007) How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag 3(4):685\u2013690","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"3171_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/mpr.7","volume":"14","author":"S Zhang","year":"2005","unstructured":"Zhang S, Faries DE, Vowles M, Michelson D (2005) ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 14(4):186\u2013201. https:\/\/doi.org\/10.1002\/mpr.7","journal-title":"Int J Methods Psychiatr Res"},{"issue":"5","key":"3171_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/s0278-5846(03)00117-9","volume":"27","author":"S Akhondzadeh","year":"2003","unstructured":"Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H (2003) Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27(5):841\u2013845. https:\/\/doi.org\/10.1016\/s0278-5846(03)00117-9","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"3171_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pnpbp.2007.07.025","volume":"32","author":"S Amiri","year":"2008","unstructured":"Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S (2008) Modafinil as a treatment for Attention-Deficit\/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 32(1):145\u2013149. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.07.025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"3171_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.22038\/ajp.2022.19714","volume":"12","author":"L Kashani","year":"2022","unstructured":"Kashani L, Aslzadeh S, Shokraee K, Shamabadi A, Tadayon Najafabadi B, Jafarinia M, Esalatmanesh S, Akhondzadeh S (2022) Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial. Avicenna J Phytomed 12(3):257\u2013268. https:\/\/doi.org\/10.22038\/ajp.2022.19714","journal-title":"Avicenna J Phytomed"},{"issue":"12","key":"3171_CR27","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s00213-023-06458-9","volume":"240","author":"A Shamabadi","year":"2023","unstructured":"Shamabadi A, Fattollahzadeh-Noor S, Fallahpour B, Khodaei Ardakani FAB, Akhondzadeh MR S (2023) L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial. Psychopharmacology 240(12):2631\u20132640. https:\/\/doi.org\/10.1007\/s00213-023-06458-9","journal-title":"Psychopharmacology"},{"issue":"6","key":"3171_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/cap.2016.0024","volume":"26","author":"E Salardini","year":"2016","unstructured":"Salardini E, Zeinoddini A, Kohi A, Mohammadi M-R, Mohammadinejad P, Khiabany M, Shahriari M, Akhondzadeh S (2016) Agomelatine as a treatment for attention-deficit\/hyperactivity disorder in children and adolescents: a double-blind, randomized clinical trial. J Child Adolesc Psychopharmacol 26(6):513\u2013519","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"3171_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/cap.2018.0146","volume":"29","author":"S Baziar","year":"2019","unstructured":"Baziar S, Aqamolaei A, Khadem E, Mortazavi SH, Naderi S, Sahebolzamani E, Mortezaei A, Jalilevand S, Mohammadi M-R, Shahmirzadi M (2019) Crocus sativus L. versus methylphenidate in treatment of children with attention-deficit\/hyperactivity disorder: A randomized, double-blind pilot study. J Child Adolesc Psychopharmacol 29(3):205\u2013212","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3171_CR30","doi-asserted-by":"publisher","unstructured":"Weiss M, Childress A, Nordbrock E, Adjei AL, Kupper RJ, Mattingly G (2019) Characteristics of ADHD Symptom Response\/Remission in a Clinical Trial of Methylphenidate Extended Release. J Clin Med 8(4). https:\/\/doi.org\/10.3390\/jcm8040461","DOI":"10.3390\/jcm8040461"},{"issue":"3","key":"3171_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40263-024-01136-6","volume":"39","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Liu H, Wang X, Li H, Ruhmann M, Mayer A, Dangel O, Ammer R (2025) Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit\/Hyperactivity Disorder (ADHD). CNS Drugs 39(3):289\u2013304. https:\/\/doi.org\/10.1007\/s40263-024-01136-6","journal-title":"CNS Drugs"},{"key":"3171_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D (2013) Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol 4:863","journal-title":"Front Psychol"},{"issue":"4","key":"3171_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s10862-021-09874-3","volume":"43","author":"CM Jungersen","year":"2021","unstructured":"Jungersen CM, Lonigan CJ (2021) Do Parent and Teacher Ratings of ADHD Reflect the Same Constructs? A Measurement Invariance Analysis. J Psychopathol Behav Assess 43(4):778\u2013792. https:\/\/doi.org\/10.1007\/s10862-021-09874-3","journal-title":"J Psychopathol Behav Assess"},{"issue":"5","key":"3171_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s10519-011-9473-2","volume":"41","author":"G McLoughlin","year":"2011","unstructured":"McLoughlin G, Rijsdijk F, Asherson P, Kuntsi J (2011) Parents and teachers make different contributions to a shared perspective on hyperactive-impulsive and inattentive symptoms: a multivariate analysis of parent and teacher ratings on the symptom domains of ADHD. Behav Genet 41(5):668\u2013679. https:\/\/doi.org\/10.1007\/s10519-011-9473-2","journal-title":"Behav Genet"},{"key":"3171_CR35","doi-asserted-by":"publisher","unstructured":"Fageera W, Traicu A, Sengupta SM, Fortier ME, Choudhry Z, Labbe A, Grizenko N, Joober R (2018) Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial. Int J Methods Psychiatr Res 27(1). https:\/\/doi.org\/10.1002\/mpr.1572","DOI":"10.1002\/mpr.1572"},{"issue":"1","key":"3171_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ijnp\/pyab054","volume":"25","author":"X Castells","year":"2022","unstructured":"Castells X, Saez M, Barcheni M, Cunill R, Serrano D, L\u00f3pez B, van Lissa CJ (2022) Placebo Response and Its Predictors in Attention Deficit Hyperactivity Disorder: A Meta-Analysis and Comparison of Meta-Regression and MetaForest. Int J Neuropsychopharmacol 25(1):26\u201335. https:\/\/doi.org\/10.1093\/ijnp\/pyab054","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"3171_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","volume":"18","author":"TR Gossard","year":"2021","unstructured":"Gossard TR, Trotti LM, Videnovic A, St Louis EK (2021) Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics 18(1):140\u2013155","journal-title":"Neurotherapeutics"},{"key":"3171_CR38","doi-asserted-by":"publisher","first-page":"108278","DOI":"10.1016\/j.neuropharm.2020.108278","volume":"179","author":"V Rawji","year":"2020","unstructured":"Rawji V, Rocchi L, Foltynie T, Rothwell JC, Jahanshahi M (2020) Ropinirole, a dopamine agonist with high D(3) affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults. Neuropharmacology 179:108278. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108278","journal-title":"Neuropharmacology"},{"issue":"2","key":"3171_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/00048670802607238","volume":"43","author":"F Levy","year":"2009","unstructured":"Levy F (2009) Dopamine vs noradrenaline: inverted-U effects and ADHD theories. Aust N Z J Psychiatry 43(2):101\u2013108. https:\/\/doi.org\/10.1080\/00048670802607238","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"3171_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1037\/bne0000512","volume":"136","author":"MA Weber","year":"2022","unstructured":"Weber MA, Conlon MM, Stutt HR, Wendt L, Ten Eyck P, Narayanan NS (2022) Quantifying the inverted U: A meta-analysis of prefrontal dopamine, D1 receptors, and working memory. Behav Neurosci 136(3):207","journal-title":"Behav Neurosci"},{"issue":"1","key":"3171_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4088\/JCP.09bs05890pur","volume":"71","author":"SM Stahl","year":"2010","unstructured":"Stahl SM (2010) Mechanism of action of stimulants in attention-deficit\/hyperactivity disorder. J Clin Psychiatry 71(1):12\u201313. https:\/\/doi.org\/10.4088\/JCP.09bs05890pur","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"3171_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1124\/jpet.122.001215","volume":"382","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lewis MM, Kong L, Mailman RB (2022) A dopamine D1 agonist versus methylphenidate in modulating prefrontal cortical working memory. J Pharmacol Exp Ther 382(2):88\u201399","journal-title":"J Pharmacol Exp Ther"},{"key":"3171_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-981-19-7376-5_15","volume-title":"Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders","author":"D V\u00e1zquez-Gonz\u00e1lez","year":"2023","unstructured":"V\u00e1zquez-Gonz\u00e1lez D, Carre\u00f3n-Trujillo S, Alvarez-Arellano L, Abarca-Merlin DM, Dom\u00ednguez-L\u00f3pez P, Salazar-Garc\u00eda M, Corona JC (2023) A Potential Role for Neuroinflammation in ADHD. In: Kim Y-K (ed) Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. Springer Nature Singapore, Singapore, pp 327\u2013356. doi:https:\/\/doi.org\/10.1007\/978-981-19-7376-5_15"},{"issue":"2","key":"3171_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/etm.2022.11777","volume":"25","author":"Y Isozaki","year":"2022","unstructured":"Isozaki Y, Sato T, Takagi R, Ito K, Usui M, Kawano M, Matsushita S (2022) Ropinirole inhibits inflammatory cytokine production in gingival epithelial cells and suppresses alveolar bone loss in an experimental rat model of periodontitis. Experimental therapeutic Med 25(2):78","journal-title":"Experimental therapeutic Med"},{"issue":"1","key":"3171_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0006-8993(99)01688-1","volume":"838","author":"M Iida","year":"1999","unstructured":"Iida M, Miyazaki I, Tanaka K-i, Kabuto H, Iwata-Ichikawa E, Ogawa N (1999) Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res 838(1):51\u201359. https:\/\/doi.org\/10.1016\/S0006-8993(99)01688-1","journal-title":"Brain Res"},{"issue":"5","key":"3171_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/pharmaceutics12050448","volume":"12","author":"N Dudhipala","year":"2020","unstructured":"Dudhipala N, Gorre T (2020) Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson\u2019s Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation. Pharmaceutics 12(5):448","journal-title":"Pharmaceutics"},{"key":"3171_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cct.2015.05.005","volume":"43","author":"J Moncrieff","year":"2015","unstructured":"Moncrieff J, Kirsch I (2015) Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemp Clin Trials 43:60\u201362. https:\/\/doi.org\/10.1016\/j.cct.2015.05.005","journal-title":"Contemp Clin Trials"},{"issue":"D1","key":"3171_CR48","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger Christen M, Franklin M, Oler E, Wilson A, Pon A, Cox J, Chin NE, Strawbridge Seth A, Garcia-Patino M, Kruger R, Sivakumaran A, Sanford S, Doshi R, Khetarpal N, Fatokun O, Doucet D, Zubkowski A, Rayat Dorsa Y, Jackson H, Harford K, Anjum A, Zakir M, Wang F, Tian S, Lee B, Liigand J, Peters H, Wang RQ, Nguyen T, So D, Sharp M, da Silva R, Gabriel C, Scantlebury J, Jasinski M, Ackerman D, Jewison T, Sajed T, Gautam V, Wishart David S (2024) DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52(D1):D1265\u2013D1275. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03171-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:28:07Z","timestamp":1787642887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-026-03171-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":48,"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03171-8","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the institutional research ethics committee (identifier IR.TUMS.MEDICINE.REC.1402.151).","order":1,"name":"Ethics","label":"Ethics approval statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors had no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients.","order":4,"name":"Ethics","label":"Patient consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Permission to reproduce material from other sources","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was registered and published in the Iranian registry of clinical trials (http:\/\/www.irct.ir; identifier IRCT20090117001556N146).","order":6,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Iranian registry of clinical trials (http:\/\/www.irct.ir); identifier: IRCT20090117001556N151; registration date: June 19, 2023.","order":7,"name":"Ethics","label":"Registry","group":{"name":"EthicsHeading","label":"Declarations"}}]}}